Ratchaphruek Hospital PCL
SET:RPH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
Ratchaphruek Hospital PCL
SET:RPH
|
TH |
|
Encourage Technologies Co Ltd
TSE:3682
|
JP |
|
Wealthking Investments Ltd
HKEX:1140
|
HK |
|
S
|
SMC Global Securities Ltd
NSE:SMCGLOBAL
|
IN |
|
NIO Inc
NYSE:NIO
|
CN |
|
Addtech AB
STO:ADDT B
|
SE |
|
B
|
Beijing Shenzhou Aerospace Software Technology Co Ltd
SSE:688562
|
CN |
|
Nexity SA
PAR:NXI
|
FR |
Balance Sheet
Balance Sheet Decomposition
Ratchaphruek Hospital PCL
Ratchaphruek Hospital PCL
Balance Sheet
Ratchaphruek Hospital PCL
| Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||
| Cash & Cash Equivalents |
69
|
35
|
17
|
118
|
58
|
169
|
69
|
49
|
159
|
238
|
317
|
325
|
291
|
280
|
|
| Cash |
69
|
0
|
17
|
118
|
58
|
169
|
69
|
49
|
159
|
238
|
317
|
325
|
291
|
280
|
|
| Cash Equivalents |
0
|
35
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
0
|
60
|
110
|
80
|
110
|
350
|
30
|
0
|
0
|
0
|
0
|
0
|
150
|
100
|
|
| Total Receivables |
15
|
23
|
18
|
18
|
20
|
19
|
32
|
48
|
56
|
374
|
175
|
110
|
85
|
100
|
|
| Accounts Receivables |
14
|
23
|
17
|
18
|
20
|
19
|
32
|
48
|
56
|
395
|
175
|
110
|
84
|
97
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
22
|
1
|
1
|
2
|
4
|
|
| Inventory |
11
|
13
|
12
|
11
|
11
|
10
|
16
|
22
|
23
|
30
|
23
|
27
|
24
|
26
|
|
| Other Current Assets |
7
|
0
|
1
|
0
|
1
|
1
|
2
|
1
|
1
|
76
|
5
|
55
|
156
|
7
|
|
| Total Current Assets |
101
|
130
|
158
|
227
|
200
|
548
|
149
|
120
|
239
|
717
|
520
|
518
|
557
|
514
|
|
| PP&E Net |
270
|
275
|
280
|
269
|
500
|
1 118
|
1 642
|
1 604
|
1 539
|
1 467
|
1 441
|
1 367
|
1 327
|
1 317
|
|
| PP&E Gross |
0
|
275
|
280
|
269
|
500
|
1 118
|
1 642
|
1 604
|
1 539
|
1 467
|
1 441
|
1 367
|
1 327
|
1 317
|
|
| Accumulated Depreciation |
0
|
146
|
75
|
87
|
101
|
112
|
151
|
236
|
316
|
394
|
486
|
558
|
630
|
669
|
|
| Intangible Assets |
2
|
2
|
1
|
3
|
7
|
6
|
7
|
7
|
6
|
5
|
26
|
23
|
19
|
16
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
|
| Long-Term Investments |
0
|
12
|
12
|
12
|
12
|
12
|
12
|
12
|
12
|
12
|
12
|
12
|
12
|
12
|
|
| Other Long-Term Assets |
0
|
3
|
3
|
3
|
3
|
5
|
7
|
9
|
8
|
13
|
9
|
11
|
12
|
48
|
|
| Total Assets |
373
N/A
|
422
+13%
|
454
+8%
|
514
+13%
|
721
+40%
|
1 689
+134%
|
1 817
+8%
|
1 751
-4%
|
1 804
+3%
|
2 215
+23%
|
2 009
-9%
|
1 932
-4%
|
1 928
0%
|
1 909
-1%
|
|
| Liabilities | |||||||||||||||
| Accounts Payable |
21
|
50
|
16
|
17
|
16
|
16
|
23
|
31
|
35
|
66
|
39
|
43
|
39
|
44
|
|
| Accrued Liabilities |
0
|
0
|
16
|
28
|
32
|
30
|
35
|
40
|
37
|
34
|
44
|
35
|
32
|
39
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
20
|
20
|
20
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
23
|
20
|
16
|
2
|
0
|
64
|
73
|
101
|
104
|
107
|
108
|
2
|
1
|
1
|
|
| Other Current Liabilities |
23
|
5
|
13
|
10
|
84
|
277
|
191
|
69
|
28
|
191
|
28
|
51
|
47
|
57
|
|
| Total Current Liabilities |
67
|
74
|
62
|
57
|
132
|
387
|
322
|
241
|
225
|
418
|
240
|
130
|
120
|
142
|
|
| Long-Term Debt |
92
|
84
|
69
|
67
|
64
|
0
|
202
|
168
|
194
|
87
|
17
|
4
|
3
|
2
|
|
| Other Liabilities |
0
|
8
|
10
|
12
|
11
|
13
|
15
|
25
|
30
|
29
|
29
|
34
|
43
|
49
|
|
| Total Liabilities |
159
N/A
|
166
+4%
|
141
-15%
|
135
-4%
|
207
+53%
|
400
+94%
|
539
+35%
|
434
-20%
|
449
+3%
|
535
+19%
|
286
-47%
|
168
-41%
|
166
-1%
|
193
+16%
|
|
| Equity | |||||||||||||||
| Common Stock |
135
|
159
|
182
|
330
|
382
|
546
|
546
|
546
|
546
|
546
|
546
|
546
|
546
|
546
|
|
| Retained Earnings |
78
|
97
|
131
|
50
|
65
|
74
|
62
|
102
|
140
|
464
|
507
|
548
|
554
|
584
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
67
|
670
|
670
|
670
|
670
|
670
|
670
|
670
|
670
|
670
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
7
|
84
|
|
| Other Equity |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
213
N/A
|
256
+20%
|
313
+23%
|
379
+21%
|
515
+36%
|
1 289
+150%
|
1 278
-1%
|
1 317
+3%
|
1 355
+3%
|
1 680
+24%
|
1 723
+3%
|
1 764
+2%
|
1 762
0%
|
1 715
-3%
|
|
| Total Liabilities & Equity |
373
N/A
|
422
+13%
|
454
+8%
|
514
+13%
|
721
+40%
|
1 689
+134%
|
1 817
+8%
|
1 751
-4%
|
1 804
+3%
|
2 215
+23%
|
2 009
-9%
|
1 932
-4%
|
1 928
0%
|
1 909
-1%
|
|
| Shares Outstanding | |||||||||||||||
| Common Shares Outstanding |
135
|
159
|
182
|
330
|
382
|
546
|
546
|
546
|
546
|
546
|
546
|
546
|
545
|
530
|
|